Translations on this website are prepared by a third-party provider. Some portions may be incorrect. Some items—including downloadable files or images—cannot be translated at all. No liability is assumed by Beth Israel Deaconess Medical Center for any errors or omissions. Any user who relies on translated content does so at his/her own risk.
The HMS Initiative for RNA Medicine brings together leading investigators in the field to pursue new lines of inquiry into non-coding RNA. View the Initiative’s series of virtual seminar presentations and other videos below.
HIRM/Precision RNA Medicine Core Detection Workshop: “Technology and Bioinformatics Tools to Facilitate Profiling of microRNA Biomarkers” Lihan Zhou, PhD, Co-Founder & Chief Executive Officer, MiRXES Pte. Ltd Doreen Chua, Marketing & Business Development Manager, MiRXES Pte. Ltd Jeremy Lim, MSc, Senior Research Scientist, MiRXES Lab Pte. Ltd Jit Kong Cheong, PhD, Head of National University of Singapore ncRNA Core Facility Ioannis Vlachos, PhD, Assistant Professor, Harvard Medical School; Co-Director of the Bioinformatics Program, Cancer Research Institute, BIDMC; Director of Bioinformatics, Precision RNA Medicine Core, Harvard Medical School Initiative for RNA Medicine
Given April 30, 2021
HIRM Annual Symposium: RNA Medicine 2021 Given April 29, 2021
The Institute for RNA Medicine at the BIDMC Cancer Center is making and translating RNA discoveries into novel therapeutics and diagnostics through the work of world-class scientists.
Beth Israel Deaconess Medical Center Pathologist Andrew Beck, MD, has developed C-Path, short for Computational Pathologist, a computer algorithm that yields highly detailed and accurate information about cancerous tissue.